Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Clinical Practice Guideline – Peripheral T- and Natural Killer-cell Lymphomas

Peripheral T- and natural killer-cell lymphomas: ESMO–EHA Clinical Practice Guideline for diagnosis, treatment and follow-up

Published online: 8 May 2025 - Annals of Oncology
d’Amore F, Federico M, de Level L, et al., on behalf of the ESMO Guidelines Committee

  • This ESMO–EHA Clinical Practice Guideline addresses the management of ‘mature’ or ‘peripheral’ T- and NK-cell lymphomas.
  • Clinical features, histopathological diagnosis, imaging, staging and risk assessment, treatment and follow-up are covered.
  • The author group encompasses a multidisciplinary group of experts from different institutions and countries.
  • Recommendations are based on available scientific data and the authors’ collective expert opinion.
  • A comprehensive supplement is included, which should be regarded as complementary to the main text for full understanding.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.